Therapeutic applications of resveratrol and its derivatives on periodontitis

Abstract Periodontitis is an inflammatory disease of the supporting tissues of the teeth induced by periodontopathic bacteria that results in the progressive destruction of periodontal tissues. Treatment of periodontitis is painful and time‐consuming. Recently, herbal medicines have been considered for use in treating inflammation‐related diseases, including periodontitis. Resveratrol and its derivative 2,3,5,4′‐tetrahydroxystilbene‐2‐ O ‐β‐glucoside (THSG), a polyphenol extracted from Polygonum multiflorum , have anti‐inflammatory properties and other medical benefits. Here, we highlight the importance of resveratrol and its glycosylated derivative as possible complementary treatments for periodontitis and their potential for development as innovative therapeutic strategies. In addition, we present evidence and discuss the mechanisms of action of resveratrol and THSG on periodontitis, focusing on Porphyromonas gingivalis –induced inflammatory responses in human gingival fibroblasts and animal modeling of ligature‐induced periodontitis. We also illuminate the signal transduction pathways and the cytokines involved.